Endometriosis Impairs Blood Vessel Function Despite Normal Platelet Activity

Women with endometriosis face significantly impaired blood vessel function that may contribute to their increased cardiovascular disease risk, according to new research from Penn State University. This finding challenges assumptions about how endometriosis affects the circulatory system.

Researchers studied 21 women, comparing 12 with endometriosis to 9 healthy controls. They used a technique called anodal current-induced vasodilation to test how well tiny blood vessels in the skin could expand. Participants received either placebo or aspirin to assess the role of cyclooxygenase enzymes in vessel function. Blood samples were analyzed for platelet activity and inflammatory markers.

The results showed women with endometriosis had markedly reduced blood vessel dilation capacity compared to healthy women. Surprisingly, despite having higher platelet counts, their platelet aggregation function was normal, contradicting expectations that endometriosis would increase clotting risk through this mechanism.

These findings suggest endometriosis impairs cardiovascular health through vascular dysfunction rather than increased blood clotting. The compromised cyclooxygenase-mediated vasodilation could contribute to the elevated heart disease risk observed in women with endometriosis, potentially through reduced blood flow capacity and impaired vascular adaptation.

For the millions of women with endometriosis, this research highlights the importance of cardiovascular monitoring and preventive care. However, the study's small size and focus on skin blood vessels limits broader conclusions about systemic cardiovascular effects.